Yuan et al. [11] developed and validated a modified CXI (mCXI), calculated using serum albumin (ALB), the neutrophil–lymphocyte ratio (NLR), and the urea–creatinine ratio (UCR), to predict the prognosis of patients with CRC after surgery. Here, ALB is linked to colorectal carcinoma.